Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Rainbow Children's Medicare Limited aims for a 20% CAGR revenue growth over the next 2.5 to 3 years, driven by significant capacity expansion including ~780 new beds. Rainbow Children’s Medicare targets around 20% CAGR revenue growth over the next 2.5 to 3 years, driven by capacity addition (~47% increase in beds), super-specialty enhancements, and acquisitions (Guwahati and Warangal).
From Rainbow Childrens Medicare Ltd's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Rainbow Children's Medicare Limited aims for a 20% CAGR revenue growth over the next 2.5 to 3 years, driven by significant capacity expansion including ~780 new beds.
- Growth is expected to be back-ended, with stronger performance in the second half due to ramp-up of acquisitions (Guwahati, Warangal) and new facilities (Rajahmundry, Bangalore).
- Mature units are expected to stabilize at 8%-10% growth, while new units and acquisitions contribute higher growth.
- Top-line growth targeting around 20% CAGR, factoring in both organic growth and M&A contributions.
2 more points from Rainbow Childrens Medicare Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Rainbow Childrens Medicare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Planned capex of approximately INR 100 crores in H2 FY26.
- Significant capex of roughly INR 600 crores anticipated over FY27 to FY29, including Pune, Coimbatore, and Gurgaon projects.
- Gurgaon project involves adding ~450 beds; land and building owned, with construction costing around INR 1.5 billion plus. Already INR 180 crores spent on land and INR 20–30 crores on preliminary work.
- Pending projects at Hennur and Electronic City in Bangalore alongside Gurugram construction continuing.
- Capex to be funded through internal accruals and current net cash position (~INR 555.8 crores as of Sept 30, 2025) without any debt financing.
2 more points from Rainbow Childrens Medicare Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Rainbow Childrens Medicare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Rainbow Children's Medicare Limited expects to spend close to INR 100 crores in H2 FY26 for ongoing projects.
- For Pune and Coimbatore projects over the next three years, the company plans a budget of roughly INR 600 crores.
- Pending projects include Hennur and Electronic City in Bangalore, along with the Gurugram project where work is ongoing.
2 more points from Rainbow Childrens Medicare Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Rainbow Childrens Medicare Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹460 Cr, net profit ₹78 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Rainbow Childrens Medicare Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Metropolis Healt (Q2 FY26)
Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…
- 3B Blackbio DX Ltd (Q2 FY26)
Q2 FY 2025-26 sales: ₹3042.83 Lakh (including COVID sales ₹10.23 Lakh), up from ₹2457.55 Lakh in Q2 FY 2024-25. Key concall takeaways from 3B Blackbio DX Ltd's…
- Indegene Ltd (Q2 FY26)
Indegene is making strategic investments ahead of the curve to capitalize on market opportunities over the next 6 to 8 quarters, which will cause near-term…
- Yatharth Hospital & Trauma Care Services Ltd (Q2 FY26)
Mature hospitals have room to increase occupancy to 75%, supporting margin and revenue growth. Key concall takeaways from Yatharth Hospital & Trauma Care…
Arthneeti Pro · Annual
Rainbow Childrens Medicare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Rainbow Childrens Medicare Ltd Q2 FY26 results?
Rainbow Children's Medicare Limited aims for a 20% CAGR revenue growth over the next 2.5 to 3 years, driven by significant capacity expansion including ~780 new beds. Rainbow Children’s Medicare targets around 20% CAGR revenue growth over the next 2.5 to 3 years, driven by capacity addition (~47% increase in beds), super-specialty enhancements, and acquisitions (Guwahati and Warangal).
What is Rainbow Childrens Medicare Ltd share price analysis?
Rainbow Childrens Medicare Ltd currently shows a neutral. The stock trades at a P/E of 44.3 with a market cap of ₹12,682 Cr. Investors should review the full earnings analysis for detailed insights.
Is Rainbow Childrens Medicare Ltd planning capital expenditure?
Planned capex of approximately INR 100 crores in H2 FY26. - Significant capex of roughly INR 600 crores anticipated over FY27 to FY29, including Pune, Coimbatore, and Gurgaon projects. - Gurgaon project involves adding ~450 beds; land and building owned, with construction costing around INR 1.5 billion plus.
Keep Rainbow Childrens Medicare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.